These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 28425994)

  • 21. The ins and outs of serine and glycine metabolism in cancer.
    Geeraerts SL; Heylen E; De Keersmaecker K; Kampen KR
    Nat Metab; 2021 Feb; 3(2):131-141. PubMed ID: 33510397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mTORC1-mediated translational elongation limits intestinal tumour initiation and growth.
    Faller WJ; Jackson TJ; Knight JR; Ridgway RA; Jamieson T; Karim SA; Jones C; Radulescu S; Huels DJ; Myant KB; Dudek KM; Casey HA; Scopelliti A; Cordero JB; Vidal M; Pende M; Ryazanov AG; Sonenberg N; Meyuhas O; Hall MN; Bushell M; Willis AE; Sansom OJ
    Nature; 2015 Jan; 517(7535):497-500. PubMed ID: 25383520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis.
    Thu PM; Zheng ZG; Zhou YP; Wang YY; Zhang X; Jing D; Cheng HM; Li J; Li P; Xu X
    Eur J Pharmacol; 2019 May; 850():23-34. PubMed ID: 30716311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overall survival of pancreatic ductal adenocarcinoma is doubled by
    Lee JS; Lee H; Woo SM; Jang H; Jeon Y; Kim HY; Song J; Lee WJ; Hong EK; Park SJ; Han SS; Kim SY
    Theranostics; 2021; 11(7):3472-3488. PubMed ID: 33537098
    [No Abstract]   [Full Text] [Related]  

  • 25. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.
    Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH
    Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells.
    Labuschagne CF; van den Broek NJ; Mackay GM; Vousden KH; Maddocks OD
    Cell Rep; 2014 May; 7(4):1248-58. PubMed ID: 24813884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth.
    Nagdas S; Kashatus JA; Nascimento A; Hussain SS; Trainor RE; Pollock SR; Adair SJ; Michaels AD; Sesaki H; Stelow EB; Bauer TW; Kashatus DF
    Cell Rep; 2019 Aug; 28(7):1845-1859.e5. PubMed ID: 31412251
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Fan TWM; Bruntz RC; Yang Y; Song H; Chernyavskaya Y; Deng P; Zhang Y; Shah PP; Beverly LJ; Qi Z; Mahan AL; Higashi RM; Dang CV; Lane AN
    J Biol Chem; 2019 Sep; 294(36):13464-13477. PubMed ID: 31337706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.
    Trobridge P; Knoblaugh S; Washington MK; Munoz NM; Tsuchiya KD; Rojas A; Song X; Ulrich CM; Sasazuki T; Shirasawa S; Grady WM
    Gastroenterology; 2009 May; 136(5):1680-8.e7. PubMed ID: 19208363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin
    Gao C; Chen G; Zhang DH; Zhang J; Kuan SF; Hu W; Esni F; Gao X; Guan JL; Chu E; Hu J
    Cell Mol Gastroenterol Hepatol; 2019; 8(4):561-578. PubMed ID: 31330317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation at Ser-181 of oncogenic KRAS is required for tumor growth.
    Barceló C; Paco N; Morell M; Alvarez-Moya B; Bota-Rabassedas N; Jaumot M; Vilardell F; Capella G; Agell N
    Cancer Res; 2014 Feb; 74(4):1190-9. PubMed ID: 24371225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycine-serine interrelations in the chick.
    Featherston WR
    Fed Proc; 1976 Jun; 35(8):1910-3. PubMed ID: 1269776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer.
    Zhang Y; Velez-Delgado A; Mathew E; Li D; Mendez FM; Flannagan K; Rhim AD; Simeone DM; Beatty GL; Pasca di Magliano M
    Gut; 2017 Jan; 66(1):124-136. PubMed ID: 27402485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.
    Xu L; Wang L; Zhou L; Dorfman RG; Pan Y; Tang D; Wang Y; Yin Y; Jiang C; Zou X; Wu J; Zhang M
    Neoplasia; 2019 May; 21(5):429-441. PubMed ID: 30933885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation.
    Ding J; Li T; Wang X; Zhao E; Choi JH; Yang L; Zha Y; Dong Z; Huang S; Asara JM; Cui H; Ding HF
    Cell Metab; 2013 Dec; 18(6):896-907. PubMed ID: 24315373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer.
    Vallejo A; Perurena N; Guruceaga E; Mazur PK; Martinez-Canarias S; Zandueta C; Valencia K; Arricibita A; Gwinn D; Sayles LC; Chuang CH; Guembe L; Bailey P; Chang DK; Biankin A; Ponz-Sarvise M; Andersen JB; Khatri P; Bozec A; Sweet-Cordero EA; Sage J; Lecanda F; Vicent S
    Nat Commun; 2017 Feb; 8():14294. PubMed ID: 28220783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.
    Weng CC; Hsieh MJ; Wu CC; Lin YC; Shan YS; Hung WC; Chen LT; Cheng KH
    Mol Cancer; 2019 May; 18(1):96. PubMed ID: 31109321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer.
    Heylen E; Verstraete P; Van Aerschot L; Geeraerts SL; Venken T; Timcheva K; Nittner D; Verbeeck J; Royaert J; Gijbels M; Uyttebroeck A; Segers H; Lambrechts D; Cools J; De Keersmaecker K; Kampen KR
    Br J Cancer; 2023 May; 128(10):1862-1878. PubMed ID: 36932191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53-mediated adaptation to serine starvation is retained by a common tumour-derived mutant.
    Humpton TJ; Hock AK; Maddocks ODK; Vousden KH
    Cancer Metab; 2018; 6():18. PubMed ID: 30524726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.